396 related articles for article (PubMed ID: 32389499)
21. The Science Underlying COVID-19: Implications for the Cardiovascular System.
Liu PP; Blet A; Smyth D; Li H
Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
Groß S; Jahn C; Cushman S; Bär C; Thum T
J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703
[TBL] [Abstract][Full Text] [Related]
23. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
[TBL] [Abstract][Full Text] [Related]
24. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
Amraei R; Rahimi N
Cells; 2020 Jul; 9(7):. PubMed ID: 32660065
[TBL] [Abstract][Full Text] [Related]
25. Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells.
Soleimani M
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380787
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 and cancer: Are they really partners in crime?
van Dam PA; Huizing M; Mestach G; Dierckxsens S; Tjalma W; Trinh XB; Papadimitriou K; Altintas S; Vermorken J; Vulsteke C; Janssens A; Berneman Z; Prenen H; Meuris L; Vanden Berghe W; Smits E; Peeters M
Cancer Treat Rev; 2020 Sep; 89():102068. PubMed ID: 32731090
[TBL] [Abstract][Full Text] [Related]
27. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
Li SR; Tang ZJ; Li ZH; Liu X
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1021-1026. PubMed ID: 32285293
[TBL] [Abstract][Full Text] [Related]
28. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Malek Mahdavi A
Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
[TBL] [Abstract][Full Text] [Related]
29. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
30. Vascular underpinning of COVID-19.
Wazny V; Siau A; Wu KX; Cheung C
Open Biol; 2020 Aug; 10(8):200208. PubMed ID: 32847471
[TBL] [Abstract][Full Text] [Related]
31. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
Cadegiani FA; Goren A; Wambier CG
Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
Hou YJ; Okuda K; Edwards CE; Martinez DR; Asakura T; Dinnon KH; Kato T; Lee RE; Yount BL; Mascenik TM; Chen G; Olivier KN; Ghio A; Tse LV; Leist SR; Gralinski LE; Schäfer A; Dang H; Gilmore R; Nakano S; Sun L; Fulcher ML; Livraghi-Butrico A; Nicely NI; Cameron M; Cameron C; Kelvin DJ; de Silva A; Margolis DM; Markmann A; Bartelt L; Zumwalt R; Martinez FJ; Salvatore SP; Borczuk A; Tata PR; Sontake V; Kimple A; Jaspers I; O'Neal WK; Randell SH; Boucher RC; Baric RS
Cell; 2020 Jul; 182(2):429-446.e14. PubMed ID: 32526206
[TBL] [Abstract][Full Text] [Related]
33. Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?
Majdic G
Front Cell Infect Microbiol; 2020; 10():327. PubMed ID: 32582576
[TBL] [Abstract][Full Text] [Related]
34. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
Rossi GA; Sacco O; Mancino E; Cristiani L; Midulla F
Infection; 2020 Oct; 48(5):665-669. PubMed ID: 32737833
[TBL] [Abstract][Full Text] [Related]
35. Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.
Beeraka NM; Sadhu SP; Madhunapantula SV; Rao Pragada R; Svistunov AA; Nikolenko VN; Mikhaleva LM; Aliev G
Front Immunol; 2020; 11():552925. PubMed ID: 33072093
[TBL] [Abstract][Full Text] [Related]
36. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
Asrani P; Hasan GM; Sohal SS; Hassan MI
OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
[TBL] [Abstract][Full Text] [Related]
37. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.
Devaux CA; Rolain JM; Raoult D
J Microbiol Immunol Infect; 2020 Jun; 53(3):425-435. PubMed ID: 32414646
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 and the cardiovascular system.
Hafiane A
Clin Chim Acta; 2020 Nov; 510():311-316. PubMed ID: 32681935
[TBL] [Abstract][Full Text] [Related]
39. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
40. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
